Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Satellos Bioscience Inc (MSCL.TO)

Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Satellos Bioscience Inc 200 Bay Street Suite 2800, Royal Bank Plaza, South Tower Toronto ON M5J 2J1 CAN

https://www.satellos.com P: 905-336-6128

Description:

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Key Statistics

Overview:

Market Capitalization, $K 96,374
Shares Outstanding, K 113,381
Annual Sales, $ 0 K
Annual Net Income, $ -15,889 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,036 K
60-Month Beta 1.36

Growth:

1-Year Return 142.86%
3-Year Return -35.61%
5-Year Return 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 08/12/24
Next Earnings Date 11/27/24
Earnings Per Share ttm -0.19
EPS Growth vs. Prev Year -25.93%
Dividend Payout Ratio 0.00%

MSCL.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -58.84%
Return-on-Assets % -53.45%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 3.30
Book Value/Share 0.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar